1. Home
  2. AUPH vs DRD Comparison

AUPH vs DRD Comparison

Compare AUPH & DRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AUPH
  • DRD
  • Stock Information
  • Founded
  • AUPH 1993
  • DRD 1895
  • Country
  • AUPH Canada
  • DRD South Africa
  • Employees
  • AUPH N/A
  • DRD N/A
  • Industry
  • AUPH Biotechnology: Pharmaceutical Preparations
  • DRD Precious Metals
  • Sector
  • AUPH Health Care
  • DRD Basic Materials
  • Exchange
  • AUPH Nasdaq
  • DRD Nasdaq
  • Market Cap
  • AUPH 1.1B
  • DRD 1.3B
  • IPO Year
  • AUPH 1999
  • DRD N/A
  • Fundamental
  • Price
  • AUPH $9.00
  • DRD $13.71
  • Analyst Decision
  • AUPH Strong Buy
  • DRD Strong Buy
  • Analyst Count
  • AUPH 2
  • DRD 1
  • Target Price
  • AUPH $11.50
  • DRD $16.25
  • AVG Volume (30 Days)
  • AUPH 2.0M
  • DRD 531.9K
  • Earning Date
  • AUPH 07-31-2025
  • DRD 01-01-0001
  • Dividend Yield
  • AUPH N/A
  • DRD 2.05%
  • EPS Growth
  • AUPH N/A
  • DRD 28.24
  • EPS
  • AUPH 0.27
  • DRD 1.05
  • Revenue
  • AUPH $247,295,000.00
  • DRD $374,318,123.00
  • Revenue This Year
  • AUPH $12.15
  • DRD $20.68
  • Revenue Next Year
  • AUPH $18.31
  • DRD $9.68
  • P/E Ratio
  • AUPH $33.08
  • DRD $12.98
  • Revenue Growth
  • AUPH 29.20
  • DRD 21.52
  • 52 Week Low
  • AUPH $5.20
  • DRD $7.64
  • 52 Week High
  • AUPH $10.67
  • DRD $17.60
  • Technical
  • Relative Strength Index (RSI)
  • AUPH 62.04
  • DRD 46.82
  • Support Level
  • AUPH $7.36
  • DRD $13.24
  • Resistance Level
  • AUPH $9.10
  • DRD $14.02
  • Average True Range (ATR)
  • AUPH 0.43
  • DRD 0.41
  • MACD
  • AUPH 0.11
  • DRD 0.03
  • Stochastic Oscillator
  • AUPH 84.20
  • DRD 51.70

About AUPH Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.

About DRD DRDGOLD Limited

DRDGold Ltd is a South African gold mining company engaged in surface gold tailings retreatment including exploration, extraction, processing, and smelting. Its reportable operating segments are; Ergo, FWGR, and Corporate office and other reconciling items. The Ergo is a surface gold retreatment operation that treats old slime dams and sand dumps to the south of Johannesburg's central business district as well as the East and Central Rand goldfields; and the FWGR which is a surface gold retreatment operation and treats old slime dams in the West Rand goldfields. The Ergo segment derives a vast majority of the company's revenue.

Share on Social Networks: